Massive medicare study tracks tiny Pacemaker's Real-World safety

This study follows about 37,000 Medicare patients who received a Micra leadless pacemaker to treat slow heart rate (bradycardia). Researchers use insurance claims data to check for complications within 30 days and survival rates over two years. The goal is to meet a government requirement for coverage and to see how well the device works in everyday practice.